Department of Gastrointestinal Surgery, The First Affiliated Hospital of the University of South China, No. 69 Chuanshan Road, Shigu District, Hengyang, 421001, Hunan, China.
Surg Endosc. 2024 Oct;38(10):5584-5595. doi: 10.1007/s00464-024-11111-3. Epub 2024 Aug 1.
A meta-analysis was conducted on the perioperative and oncological outcomes of robot-assisted and laparoscopic lateral lymph node dissection in rectal cancer. There are few articles and reports on this topic, and a lack of high-quality research results in unreliable research conclusions. This study includes prospective and retrospective studies to obtain more reliable findings.
Databases were searched, including PubMed, EMBASE, Cochrane, and Web of Science. The search was conducted from the time of database construction to March 2024. The quality of the literature was evaluated using the NOS scoring system. Meta-analysis was performed using R language software. Statistical heterogeneity was assessed using the I statistic, and sensitivity analysis was performed.
Six relevant literatures that met the criteria were finally included, and 652 patients were included, including 316 (48.5%) in the robot-assisted lateral lymph node dissection for rectal cancer group (RLLND) and 336 (51.5%) in the laparoscopic lateral lymph node dissection for rectal cancer group (LLLND). Analysis of the results showed that compared with the laparoscopic group, the robotic group had less mean intraoperative blood loss (MD = - 22, 95% CI - 40.03 to - 3.97, P < 0.05), longer operative time (MD = 51.57, 95%CI 7.69 to 95.45, P < 0.05), and a shorter mean hospital stay (MD = - 1.25, 95%CI - 2.46 to - 0.05, P < 0.05), a low rate of urinary complications (OR 0.39, 95%CI 0.23 to 0.64, P < 0.01), a low overall rate of postoperative complications (OR 0.6, 95%CI 0.42 to 0.87, P < 0.01), and a high number of lateral lymph node dissection (MD = 1.18, 95% CI 0.14 to 2.23, P < 0.05), and there was no statistically significant difference between the two groups in terms of postoperative anastomotic leakage, postoperative intestinal obstruction, and total number of lymph nodes obtained (P > 0.05).
Compared with laparoscopy, robotic lateral lymph node dissection for rectal cancer reduces intraoperative blood loss, shortens the average length of hospital stay, reduces urologic complications, decreases overall postoperative complications, and collects more lateral lymph nodes. However, the surgical time is prolonged.
对直肠癌机器人辅助与腹腔镜侧方淋巴结清扫的围手术期和肿瘤学结果进行了荟萃分析。关于这个主题的文章和报告很少,而且研究结果不可靠,缺乏高质量的研究结果。本研究包括前瞻性和回顾性研究,以获得更可靠的发现。
检索了包括 PubMed、EMBASE、Cochrane 和 Web of Science 在内的数据库。检索时间从数据库建立到 2024 年 3 月。使用 NOS 评分系统评估文献质量。使用 R 语言软件进行荟萃分析。使用 I 统计量评估统计异质性,并进行敏感性分析。
最终纳入了 6 篇符合标准的相关文献,共纳入 652 例患者,其中机器人辅助直肠癌侧方淋巴结清扫组(RLLND)316 例(48.5%),腹腔镜直肠癌侧方淋巴结清扫组(LLLND)336 例(51.5%)。结果分析表明,与腹腔镜组相比,机器人组术中平均失血量较少(MD=-22,95%CI-40.03 至-3.97,P<0.05),手术时间较长(MD=51.57,95%CI7.69 至 95.45,P<0.05),平均住院时间较短(MD=-1.25,95%CI-2.46 至-0.05,P<0.05),尿并发症发生率较低(OR 0.39,95%CI0.23 至 0.64,P<0.01),术后总体并发症发生率较低(OR 0.6,95%CI0.42 至 0.87,P<0.01),侧方淋巴结清扫数较多(MD=1.18,95%CI0.14 至 2.23,P<0.05),两组术后吻合口漏、术后肠梗阻和总淋巴结数的差异均无统计学意义(P>0.05)。
与腹腔镜相比,机器人辅助直肠癌侧方淋巴结清扫术可减少术中失血量,缩短平均住院时间,减少尿系并发症,降低术后总体并发症发生率,增加侧方淋巴结清扫数。然而,手术时间延长。